The SOCS-Box of HIV-1 Vif Interacts with ElonginBC by Induced-Folding to Recruit Its Cul5-Containing Ubiquitin Ligase Complex
The HIV-1 viral infectivity factor (Vif) protein recruits an E3 ubiquitin ligase complex, comprising the cellular proteins elongin B and C (EloBC), cullin 5 (Cul5) and RING-box 2 (Rbx2), to the anti-viral proteins APOBEC3G (A3G) and APOBEC3F (A3F) and induces their polyubiquitination and proteasomal degradation. In this study, we used purified proteins and direct in vitro binding assays, isothermal titration calorimetry and NMR spectroscopy to describe the molecular mechanism for assembly of the Vif-EloBC ternary complex. We demonstrate that Vif binds to EloBC in two locations, and that both interactions induce structural changes in the SOCS box of Vif as well as EloBC. In particular, in addition to the previously established binding of Vif's BC box to EloC, we report a novel interaction between the conserved Pro-Pro-Leu-Pro motif of Vif and the C-terminal domain of EloB. Using cell-based assays, we further show that this interaction is necessary for the formation of a functional ligase complex, thus establishing a role of this motif. We conclude that HIV-1 Vif engages EloBC via an induced-folding mechanism that does not require additional co-factors, and speculate that these features distinguish Vif from other EloBC specificity factors such as cellular SOCS proteins, and may enhance the prospects of obtaining therapeutic inhibitors of Vif function.
Vyšlo v časopise:
The SOCS-Box of HIV-1 Vif Interacts with ElonginBC by Induced-Folding to Recruit Its Cul5-Containing Ubiquitin Ligase Complex. PLoS Pathog 6(6): e32767. doi:10.1371/journal.ppat.1000925
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000925
Souhrn
The HIV-1 viral infectivity factor (Vif) protein recruits an E3 ubiquitin ligase complex, comprising the cellular proteins elongin B and C (EloBC), cullin 5 (Cul5) and RING-box 2 (Rbx2), to the anti-viral proteins APOBEC3G (A3G) and APOBEC3F (A3F) and induces their polyubiquitination and proteasomal degradation. In this study, we used purified proteins and direct in vitro binding assays, isothermal titration calorimetry and NMR spectroscopy to describe the molecular mechanism for assembly of the Vif-EloBC ternary complex. We demonstrate that Vif binds to EloBC in two locations, and that both interactions induce structural changes in the SOCS box of Vif as well as EloBC. In particular, in addition to the previously established binding of Vif's BC box to EloC, we report a novel interaction between the conserved Pro-Pro-Leu-Pro motif of Vif and the C-terminal domain of EloB. Using cell-based assays, we further show that this interaction is necessary for the formation of a functional ligase complex, thus establishing a role of this motif. We conclude that HIV-1 Vif engages EloBC via an induced-folding mechanism that does not require additional co-factors, and speculate that these features distinguish Vif from other EloBC specificity factors such as cellular SOCS proteins, and may enhance the prospects of obtaining therapeutic inhibitors of Vif function.
Zdroje
1. PetroskiMD
DeshaiesRJ
2005 Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6 9 20
2. WillemsAR
SchwabM
TyersM
2004 A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin. Biochim Biophys Acta 1695 133 170
3. MahrourN
RedwineWB
FlorensL
SwansonSK
Martin-BrownS
2008 Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to Elongin BC-based ubiquitin ligases. J Biol Chem 283 8005 8013
4. KamuraT
MaenakaK
KotoshibaS
MatsumotoM
KohdaD
2004 VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev 18 3055 3065
5. BullockAN
DebreczeniJE
EdwardsAM
SundstromM
KnappS
2006 Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase. Proc Natl Acad Sci U S A 103 7637 7642
6. BullockAN
RodriguezMC
DebreczeniJE
SongyangZ
KnappS
2007 Structure of the SOCS4-ElonginB/C complex reveals a distinct SOCS box interface and the molecular basis for SOCS-dependent EGFR degradation. Structure 15 1493 1504
7. BabonJJ
SaboJK
SoetopoA
YaoS
BaileyMF
2008 The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase. J Mol Biol 381 928 940
8. MalimMH
EmermanM
2008 HIV-1 accessory proteins–ensuring viral survival in a hostile environment. Cell Host Microbe 3 388 398
9. YuX
YuY
LiuB
LuoK
KongW
2003 Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302 1056 1060
10. SheehyAM
GaddisNC
ChoiJD
MalimMH
2002 Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418 646 650
11. ChenG
HeZ
WangT
XuR
YuXF
2009 A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G. J Virol 83 8674 8682
12. HeZ
ZhangW
ChenG
XuR
YuXF
2008 Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction. J Mol Biol 381 1000 1011
13. RussellRA
PathakVK
2007 Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F. J Virol 81 8201 8210
14. MehleA
WilsonH
ZhangC
BrazierAJ
McPikeM
2007 Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding. J Virol 81 13235 13241
15. TianC
YuX
ZhangW
WangT
XuR
2006 Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F. J Virol 80 3112 3115
16. XiaoZ
XiongY
ZhangW
TanL
EhrlichE
2007 Characterization of a novel Cullin5 binding domain in HIV-1 Vif. J Mol Biol 373 541 550
17. XiaoZ
EhrlichE
YuY
LuoK
WangT
2006 Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif. Virology 349 290 299
18. MehleA
ThomasER
RajendranKS
GabuzdaD
2006 A zinc-binding region in Vif binds Cul5 and determines cullin selection. J Biol Chem 281 17259 17265
19. LuoK
XiaoZ
EhrlichE
YuY
LiuB
2005 Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G. Proc Natl Acad Sci U S A 102 11444 11449
20. YuY
XiaoZ
EhrlichES
YuX
YuXF
2004 Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev 18 2867 2872
21. SimonJH
SheehyAM
CarpenterEA
FouchierRA
MalimMH
1999 Mutational analysis of the human immunodeficiency virus type 1 Vif protein. J Virol 73 2675 2681
22. YangS
SunY
ZhangH
2001 The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle. J Biol Chem 276 4889 4893
23. DonahueJP
VetterML
MukhtarNA
D'AquilaRT
2008 The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation. Virology 377 49 53
24. KataropoulouA
BovolentaC
BelfioreA
TrabattiS
GarbelliA
2009 Mutational analysis of the HIV-1 auxiliary protein Vif identifies independent domains important for the physical and functional interaction with HIV-1 reverse transcriptase. Nucleic Acids Res 37 3660 3669
25. StanleyBJ
EhrlichES
ShortL
YuY
XiaoZ
2008 Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly. J Virol 82 8656 8663
26. BarraudP
PaillartJC
MarquetR
TisneC
2008 Advances in the structural understanding of Vif proteins. Curr HIV Res 6 91 99
27. ZhouP
LugovskoyAA
WagnerG
2001 A solubility-enhancement tag (SET) for NMR studies of poorly behaving proteins. J Biomol NMR 20 11 14
28. SchreiberG
2002 Kinetic studies of protein-protein interactions. Curr Opin Struct Biol 12 41 47
29. OkhrimenkoO
JelesarovI
2008 A survey of the year 2006 literature on applications of isothermal titration calorimetry. J Mol Recognit 21 1 19
30. SunZY
FruehDP
SelenkoP
HochJC
WagnerG
2005 Fast assignment of 15N-HSQC peaks using high-resolution 3D HNcocaNH experiments with non-uniform sampling. J Biomol NMR 33 43 50
31. DysonHJ
WrightPE
2002 Insights into the structure and dynamics of unfolded proteins from nuclear magnetic resonance. Adv Protein Chem 62 311 340
32. MarshJA
SinghVK
JiaZ
Forman-KayJD
2006 Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: implications for fibrillation. Protein Sci 15 2795 2804
33. TakeuchiK
NgE
MaliaTJ
WagnerG
2007 1-13C amino acid selective labeling in a 2H15N background for NMR studies of large proteins. J Biomol NMR 38 89 98
34. CaseDA
2002 Molecular dynamics and NMR spin relaxation in proteins. Acc Chem Res 35 325 331
35. KnauthK
CartwrightE
FreundS
BycroftM
BuchbergerA
2009 VHL mutations linked to type 2C von Hippel-Lindau disease cause extensive structural perturbations in pVHL. J Biol Chem 284 10514 10522
36. FeldmanDE
ThulasiramanV
FerreyraRG
FrydmanJ
1999 Formation of the VHL-elongin BC tumor suppressor complex is mediated by the chaperonin TRiC. Mol Cell 4 1051 1061
37. BrowerCS
ShilatifardA
MatherT
KamuraT
TakagiY
1999 The elongin B ubiquitin homology domain. Identification of Elongin B sequences important for interaction with Elongin C. J Biol Chem 274 13629 13636
38. HuthoffH
MalimMH
2007 Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation. J Virol 81 3807 3815
39. ShiJ
GhirlandoR
BeavilRL
BeavilAJ
KeownMB
1997 Interaction of the low-affinity receptor CD23/Fc epsilonRII lectin domain with the Fc epsilon3-4 fragment of human immunoglobulin E. Biochemistry 36 2112 2122
40. DelaglioF
GrzesiekS
VuisterGW
ZhuG
PfeiferJ
1995 NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6 277 293
41. GoddardTDK
GD
2007 SPARKY 3. University of California, San Francisco
42. JohnsonBA
2004 Using NMRView to visualize and analyze the NMR spectra of macromolecules. Methods Mol Biol 278 313 352
43. PlattEJ
WehrlyK
KuhmannSE
ChesebroB
KabatD
1998 Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 72 2855 2864
44. SimonJH
SoutherlingTE
PetersonJC
MeyerBE
MalimMH
1995 Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J Virol 69 4166 4172
45. NewmanEN
HolmesRK
CraigHM
KleinKC
LingappaJR
2005 Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr Biol 15 166 170
46. ZhengN
SchulmanBA
SongL
MillerJJ
JeffreyPD
2002 Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416 703 709
47. ThompsonJD
GibsonTJ
HigginsDG
2002 Multiple sequence alignment using ClustalW and ClustalX. Curr Protoc Bioinformatics Chapter 2 Unit 2 3
48. KelleyLA
SternbergMJ
2009 Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4 363 371
49. GouetP
RobertX
CourcelleE
2003 ESPript/ENDscript: Extracting and rendering sequence and 3D information from atomic structures of proteins. Nucleic Acids Res 31 3320 3323
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 6
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Requirement of NOX2 and Reactive Oxygen Species for Efficient RIG-I-Mediated Antiviral Response through Regulation of MAVS Expression
- Formation of Complexes at Plasmodesmata for Potyvirus Intercellular Movement Is Mediated by the Viral Protein P3N-PIPO
- Insight into the Mechanisms of Adenovirus Capsid Disassembly from Studies of Defensin Neutralization
- Two Novel Point Mutations in Clinical Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection